USNA

USANA Health SciencesNYSE:USNA Stock Report

Market Cap

US$1.8b

7D

-9.2%

1Y

18.0%

Updated

18 Sep, 2021

Data

Company Financials +
USNA fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends0/6

USNA Overview

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products.

USANA Health Sciences Competitors

Price History & Performance

Summary of all time highs, changes and price drops for USANA Health Sciences
Historical stock prices
Current Share PriceUS$88.92
52 Week HighUS$72.03
52 Week LowUS$107.85
Beta0.86
1 Month Change-5.96%
3 Month Change-11.71%
1 Year Change17.98%
3 Year Change-25.43%
5 Year Change30.15%
Change since IPO14,492.00%

Recent News & Updates

Sep 15
USANA Health Sciences (NYSE:USNA) Is Aiming To Keep Up Its Impressive Returns

USANA Health Sciences (NYSE:USNA) Is Aiming To Keep Up Its Impressive Returns

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...

Shareholder Returns

USNAUS Personal ProductsUS Market
7D-9.2%-4.2%-0.6%
1Y18.0%50.8%33.8%

Return vs Industry: USNA underperformed the US Personal Products industry which returned 50.8% over the past year.

Return vs Market: USNA underperformed the US Market which returned 33.8% over the past year.

Price Volatility

Is USNA's price volatile compared to industry and market?
USNA volatility
USNA Beta0.86
Industry Beta1.04
Market Beta1

Stable Share Price: USNA is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: USNA's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19921,943Kevin Guesthttps://www.usana.com

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups.

USANA Health Sciences Fundamentals Summary

How do USANA Health Sciences's earnings and revenue compare to its market cap?
USNA fundamental statistics
Market CapUS$1.78b
Earnings (TTM)US$138.99m
Revenue (TTM)US$1.25b

12.8x

P/E Ratio

1.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
USNA income statement (TTM)
RevenueUS$1.25b
Cost of RevenueUS$230.04m
Gross ProfitUS$1.02b
ExpensesUS$884.81m
EarningsUS$138.99m

Last Reported Earnings

Jul 03, 2021

Next Earnings Date

n/a

Earnings per share (EPS)6.68
Gross Margin81.65%
Net Profit Margin11.09%
Debt/Equity Ratio0.0%

How did USNA perform over the long term?

See historical performance and comparison

Valuation

Is USANA Health Sciences undervalued compared to its fair value and its price relative to the market?

20.8%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: USNA ($88.92) is trading below our estimate of fair value ($112.23)

Significantly Below Fair Value: USNA is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: USNA is good value based on its PE Ratio (12.8x) compared to the US Personal Products industry average (16.8x).

PE vs Market: USNA is good value based on its PE Ratio (12.8x) compared to the US market (17.8x).


Price to Earnings Growth Ratio

PEG Ratio: USNA's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: USNA is overvalued based on its PB Ratio (4.3x) compared to the US Personal Products industry average (2.8x).


Future Growth

How is USANA Health Sciences forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

-3.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: USNA's earnings are forecast to decline over the next 3 years (-3.5% per year).

Earnings vs Market: USNA's earnings are forecast to decline over the next 3 years (-3.5% per year).

High Growth Earnings: USNA's earnings are forecast to decline over the next 3 years.

Revenue vs Market: USNA's revenue (0.3% per year) is forecast to grow slower than the US market (9.8% per year).

High Growth Revenue: USNA's revenue (0.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if USNA's Return on Equity is forecast to be high in 3 years time


Past Performance

How has USANA Health Sciences performed over the past 5 years?

7.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: USNA has high quality earnings.

Growing Profit Margin: USNA's current net profit margins (11.1%) are higher than last year (10.4%).


Past Earnings Growth Analysis

Earnings Trend: USNA's earnings have grown by 7.3% per year over the past 5 years.

Accelerating Growth: USNA's earnings growth over the past year (26.4%) exceeds its 5-year average (7.3% per year).

Earnings vs Industry: USNA earnings growth over the past year (26.4%) underperformed the Personal Products industry 54.7%.


Return on Equity

High ROE: USNA's Return on Equity (33.2%) is considered high.


Financial Health

How is USANA Health Sciences's financial position?


Financial Position Analysis

Short Term Liabilities: USNA's short term assets ($381.5M) exceed its short term liabilities ($153.0M).

Long Term Liabilities: USNA's short term assets ($381.5M) exceed its long term liabilities ($19.8M).


Debt to Equity History and Analysis

Debt Level: USNA is debt free.

Reducing Debt: USNA has no debt compared to 5 years ago when its debt to equity ratio was 0.01%.

Debt Coverage: USNA has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: USNA has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is USANA Health Sciences's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate USNA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate USNA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if USNA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if USNA's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of USNA's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.8yrs

Average management tenure


CEO

Kevin Guest (58 yo)

4.83yrs

Tenure

US$3,960,410

Compensation

Mr. Kevin G. Guest serves as Chairman of the Board of USANA Health Sciences, Inc. since May 1, 2020 and its Chief Executive Officer since November 23, 2016. Mr. Guest served as Co-Chief Executive Officer o...


CEO Compensation Analysis

Compensation vs Market: Kevin's total compensation ($USD3.96M) is about average for companies of similar size in the US market ($USD3.69M).

Compensation vs Earnings: Kevin's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: USNA's management team is considered experienced (4.8 years average tenure).


Board Members

Experienced Board: USNA's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: USNA insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

USANA Health Sciences, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: USANA Health Sciences, Inc.
  • Ticker: USNA
  • Exchange: NYSE
  • Founded: 1992
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: US$1.779b
  • Shares outstanding: 20.01m
  • Website: https://www.usana.com

Number of Employees


Location

  • USANA Health Sciences, Inc.
  • 3838 West Parkway Boulevard
  • Salt Lake City
  • Utah
  • 84120
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/18 22:06
End of Day Share Price2021/09/17 00:00
Earnings2021/07/03
Annual Earnings2021/01/02


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.